Actively Recruiting
Prospective Cohort Study of the Risk of Recurrent Atrial Fibrillation After Radiofrequency Ablation
Led by Peking University Third Hospital · Updated on 2024-02-21
300
Participants Needed
1
Research Sites
208 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
In this study, the continuous inclusion of atrial fibrillation patients treated by catheter ablation in the Department of Cardiology, Peking University Third Hospital, through the collection of clinical data and outpatient follow-up, to explore the risk factors of atrial fibrillation recurrence after catheter ablation and the influencing factors of major clinical events in atrial fibrillation patients, and further guide the management mode of atrial fibrillation patients.
CONDITIONS
Official Title
Prospective Cohort Study of the Risk of Recurrent Atrial Fibrillation After Radiofrequency Ablation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age > 18
- Diagnosis of atrial fibrillation confirmed by ECG or holter electrocardiogram
You will not qualify if you...
- Hematological diseases, autoimmune diseases, or malignant tumors
- Immobility caused by hemiplegia or severe trauma
- Expected survival time less than 2 years
- Poor compliance with high risk of loss to follow-up
- Disorders of consciousness or Alzheimer's disease
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Peking-University-Third-Hospital
Beijing, China
Actively Recruiting
Research Team
Y
Yanguang Li, Doctor
CONTACT
P
Pengxin Xie, master
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here